NCT05257629View on ClinicalTrials.gov

Aggressive Smoking Cessation Trial (ASAP)

PHASE3RecruitingINTERVENTIONAL
Enrollment

798

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

March 7, 2026

Study Completion Date

March 7, 2027

Conditions
Acute Coronary SyndromeCardiovascular Diseases
Interventions
COMBINATION_PRODUCT

Combination Therapy Arm (Varenicline and Nicotine E-Cigarettes Plus Counseling)

Varenicline and nicotine e-cigarettes plus counseling

OTHER

Varenicline Plus Counseling

Varenicline plus counseling

Trial Locations (13)

V3L 3W4

RECRUITING

Fraser Clinical Trials, New Westminster

E1C 2Z3

RECRUITING

Dr. Georges-L.-Dumont University Hospital Center, Moncton

A1B 3V6

RECRUITING

NL Health Sciences, St. John's

B3H 3A7

RECRUITING

Queen Elizabeth II Health Sciences Center, Halifax

Unknown

RECRUITING

St. Joseph's Hospital, London

K1Y 4W7

RECRUITING

University of Ottawa Heart Institute, Ottawa

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

H1T 1C8

RECRUITING

Montreal Heart Institute, Montreal

H2X 3E4

RECRUITING

Centre Hospitalier de L'Universite de Montreal, Montreal

H3G 1A4

RECRUITING

Montreal General Hospital, Montreal

H3T 1E2

RECRUITING

Jewish General Hospital, Montreal

G1V 4G5

RECRUITING

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec

S7N 0W8

RECRUITING

Royal University Hospital, Saskatoon

All Listed Sponsors
lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER